XML 30 R21.htm IDEA: XBRL DOCUMENT

Certain Financial Statement Caption Information (Tables)

9 Months Ended

Sep. 30, 2023

Certain Financial Statement Caption Information [Abstract]

Schedule of Company's Short-Term Investments

The following table summarizes the Company’s short-term investments (in thousands):


		Maturity		Amortized				Unrealized				Unrealized				Estimated
		(in years)		Cost				Gains				Losses				Fair Value
September 30, 2023
U.S. treasury securities		1 or less		$	11,936			$	-			$	(12	)		$	11,924
Total				$	11,936			$	-			$	(12	)		$	11,924
December 31, 2022
U.S. treasury securities		1 or less		$	12,006				-				(90	)		$	11,916
Total				$	12,006			$	-			$	(90	)		$	11,916

Schedule of Accrued Expenses

Accrued expenses consisted of the following (in thousands):


		September 30,				December 31,
		2023				2022
Clinical development		$	4,368			$	3,253
Accrued payroll and other employee benefits			2,359				2,975
Other accruals			595				472
Income tax			564				-
Non-clinical research			418				465
Accrued interest			-				74
Total accrued expenses		$	8,304			$	7,239